Exogenous sex hormones and thrombophilia.
Worldwide, hundreds of millions of women use exogenous estrogens in contraceptives or for postmenopausal hormone replacement. Exogenous estrogens increase the risk for venous and arterial thrombosis. This article reviews the use of exogenous sex hormones in women with thrombophilia.
Walker
Isobel D
ID
Glasgow Royal Infirmary, 3rd Floor Macewen Building, Castle Street, Glasgow, Scotland, G4 0SF, United Kingdom. isobel.walker@northglasgow.scot.nhs.uk
D001158:Arteries; D003278:Contraceptives, Oral, Hormonal / Q000009:adverse effects; D015914:Estrogen Replacement Therapy / Q000009:adverse effects; D004967:Estrogens / Q000009:adverse effects*; D005260:Female; D006801:Humans; D027724:Reproductive Techniques, Assisted / Q000009:adverse effects; D012307:Risk Factors; D019851:Thrombophilia / Q000139:chemically induced*; D013927:Thrombosis / Q000139:chemically induced; D020246:Venous Thrombosis / Q000139:chemically induced
D003278:Contraceptives, Oral, Hormonal; D004967:Estrogens